Elanix Biotechnologies AG (DB:ELN) announced a private placement of 679,920 no-par value bearer shares at €1.28 per share for gross proceeds of €870,297.60 on May 28, 2018. Pursuant to the transaction, the company's share capital will increase from €7,099,219 to €7,779,139. The new shares are entitled to dividends for the 2018 financial year and are to be offered to institutional investors. The transaction was approved by the management board of the company. The exact number of new shares to be issued will be determined by the management board with the approval of the supervisory board in due course.